Scancell Holdings (LSE:SCLP) Dividend Payout Ratio : 0.00 (As of Oct. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Scancell Holdings Dividend Payout Ratio?

Scancell Holdings's dividend payout ratio for the months ended in Oct. 2023 was 0.00.

The historical rank and industry rank for Scancell Holdings's Dividend Payout Ratio or its related term are showing as below:

LSE:SCLP's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.445
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-14), the Dividend Yield % of Scancell Holdings is 0.00%.

Scancell Holdings's Dividends per Share for the months ended in Oct. 2023 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Scancell Holdings Dividend Payout Ratio Historical Data

The historical data trend for Scancell Holdings's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Dividend Payout Ratio Chart

Scancell Holdings Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Dividend Payout Ratio

Get a 7-Day Free Trial

Scancell Holdings Semi-Annual Data
	Apr14	Oct14	Apr15	Oct15	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Apr20	Oct20	Apr21	Oct21	Apr22	Oct22	Apr23	Oct23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Scancell Holdings's Dividend Payout Ratio

For the Biotechnology subindustry, Scancell Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scancell Holdings's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Dividend Payout Ratio falls into.

Scancell Holdings Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Scancell Holdings's Dividend Payout Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Apr. 2023 )	/	EPS without NRI (A: Apr. 2023 )
	=	0	/	-0.014
	=	N/A

Scancell Holdings's Dividend Payout Ratio for the quarter that ended in Oct. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Oct. 2023 )	/	EPS without NRI (Q: Oct. 2023 )
	=	0	/	-0.007
	=	N/A

Scancell Holdings (LSE:SCLP) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Scancell Holdings Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Scancell Holdings (LSE:SCLP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (LSE:SCLP) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

SCLP.GB:UK SCP:Germany

Address

Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD

Website

https://www.scancell.co.uk

Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (LSE:SCLP) Headlines

No Headlines